Schizophrenia - PowerPoint PPT Presentation

1 / 71
About This Presentation
Title:

Schizophrenia

Description:

Note: Only one Criterion A symptom is required if delusions are bizarre or ... MHL in community and primary care, high index of suspicion and low threshold ... – PowerPoint PPT presentation

Number of Views:63
Avg rating:3.0/5.0
Slides: 72
Provided by: silb3
Category:

less

Transcript and Presenter's Notes

Title: Schizophrenia


1
Schizophrenia related psychoses
2
Schizophrenia
3
Schizophrenia psychosocial
4
Schizophrenia neurobiology
5
Schizophrenia neurobiology
6
Schizophrenia epidemiology
7
SCZ neurodevelopmental model of aetiology
8
Neurodevelopmental Pantelis
Figure 1.  Illustration of our proposed model.
Shaded areas represent periods of structural
brain change associated with the disorder, with
functions maturing at these times shown below. We
suggest that the functional consequences of
structural brain changes in schizophrenia are
developmentally moderated such that the later in
life a functional component comes 'online', the
more likely it is to be defective
Pantelis, Christos, Yücel, Murat, Wood, Stephen
J., McGorry, Patrick D. Velakoulis, Dennis?arly
and late neurodevelopmental disturbances in
schizophrenia and their functional
consequences.?Australian and New Zealand Journal
of Psychiatry 37 (4), 399-406.
9
Pantelis neurodevelopmental
  • Early neurodevelopmental/structural insult
  • Compensation in infancy
  • More brain plasticity
  • Functions that come online earlier e.g. motor are
    saved
  • Impairment of functions that develop later
  • Multi-circuit functions involving the frontal
    lobe e.g. working memory, executive functions lt
  • Less brain plasticity to deal with developmental
    functional demands in adolescence
  • 2nd insult/maturational abnormality e.g. as
    reflected in hippocampal volume
  • Long term neurodevelopmental/cognitive effects of
    illness possibly reflected in ongoing structural
    damage

10
More evidence for neurodevelopmental model
This multi-stage, multi-influence model may
account for heterogeneity of schizophrenia
11
Schizophrenia Aetiology
doomed from the womb second hit or
hits
12
Cannabis SCZ
13
Cannabis SCZ theories
14
Course
15
Schizophrenia Early onset
16
Schizophrenia Good prognosis
17
Schizophrenia
  • A. Characteristic symptoms Two (or more) of the
    following, each present for a significant portion
    of time during a 1-month period (or less if
    successfully treated)
  • (1) delusions(2) hallucinations(3)
    disorganized speech (e.g., frequent derailment or
    incoherence)(4) grossly disorganized or
    catatonic behavior(5) negative symptoms, i.e.,
    affective flattening, alogia, or avolition
  • Note Only one Criterion A symptom is required if
    delusions are bizarre or hallucinations consist
    of a voice keeping up a running commentary on the
    person's behaviour or thoughts, or two or more
    voices conversing with each other.

18
Schizophrenia
  • B Social/occupational dysfunction or failure to
    achieve expected function
  • C Duration 6 months incl. 1/12 active phase (NB
    ICD doesnt have 6 months)
  • D Schizoaffective/mood disorder exclusion mood
    episodes brief relative to overall illness no
    concurrent MDD, mania, mixed affective episode
  • E Substance/general Med exclusion
  • F Relationship with PDD additional prominent
    delusions, hallucinations for 1/12

19
Schizophrenia symptom complexes
20
Schizophrenia types
Hierarchical i.e. catatonic trumps disorganized
21
Schizophrenia types
22
Old age gt45 onset schizophrenia
23
Schizophrenia DDx
-ve symptoms vs. MDD AFFECT intensely painful
in MDD vs. blunted in scz
24
Management of schizophrenia at different stages
of illness
  • From the college CPG 2004

OPTIMISM is evidence-based And is the
fundamental guideline
25
Prodromal schizophrenia
26
First episode psychosis
If first episode is schizoaffective use
adjunctive mood-stabiliser for manic and
antidepressant (SSRI ? SNRI ? TCA ? ECT) for
depressed type DUP worse symptoms at
admission, poorer response to tx in medium term,
poorer social re-integration BUT no evidence it
increases impairment on cognitive testing
27
First episode psychosis
28
Why reduce DUP/DUI?
  • Decreased
  • Readmission
  • Suicide
  • DA abuse
  • Homelessness
  • Negative symptoms
  • Increased
  • Recovery (more rapid resolution of Sx)
  • Family support
  • Social support and Fx
  • QOL

29
Mx - FEP
  • 5 Ss
  • Safety assess risks
  • Setting aim for home, avoid PICU if hospital
    needed
  • Status least restrictive
  • Sx early assertive Rx
  • Specific instructions - family, pt, GP
  • - in-pt minimise trauma, 11 nursing
    for highly agitated young patients
  • Dx and Fx clarification
  • Detailed history pt and other informants
    prodromal Sx and DUI/DUP, presence of mood
    symptoms, substance use, developmental Hx
  • Early family meeting education, engagement,
    information
  • Liaison with other key informants GP
  • Physical examination esp. neuro (movement
    disorder), also wt/BMI
  • Investigations
  • MRI, ECG
  • Fasting Lipids / glucose, FBE, UE, TFT, UDS
  • MDT Neuropsych, OT ax

30
Mx - FEP
  • 3. Barriers to Rx
  • Cognitive /negative Sx
  • Adverse effects
  • Personality
  • Specific Sx / Substances
  • Insight
  • Chaotic lifestyle
  • Under influence others
  • Means / money
  • 4. Engagement strong working alliance with pt
    and carers
  • Attitudes
  • Early engagement (ideally in prodrome) incl.
    carer/consumer gps
  • Roles
  • Others involve family early educate, support,
    build alliance
  • Boundaries confidentiality NB as far as
    possible
  • Information education, MHL
  • Negotiated Rx plan
  • Goals

31
Specific interventions Dx and co-morbidity
  • Bio start low, go slow, provide info, general
    prescribing principles
  • 24-48 hr BDZ only
  • Use of benzos for behavioural agitation,
    insomnia, distress
  • Start atypical slowly over 1 week (R2, O10, Q300,
    As400, Ar15)
  • Wait 3 weeks
  • ?to R4, O20, Q600, As800, Ar 30 over 4 weeks
  • Use clozapine if 2 agents for 6 weeks each have
    failed (including 1 atypical) or prominent
    suicidal ideation
  • Continue for 12 -24 months then wean over
    several months if in remission (but 70-90 will
    relapse difficult to predict)
  • Co-morbidity / Diff Dx
  • Mood stabiliser in maniform psychosis,
    Antidepressant in depressive S-A-D
  • Substance abuse
  • Other common co-morbidities OCD, PTSD, Panic,
    Social Phobia

32
Specific interventions Dx and co-morbidity
  • Psychosocial target at key problems/issues
  • Manage trauma minimise, screen for PTS Sx,
    allow opportunity to ventilate and debrief,
    provide info on admission
  • MDT Social work finances, accommodation
  • Active use of NGOs, consumer and carer
    consultants and groups
  • PE Key intervention improve MHL, improve
    adherence, improve pt satisfaction with Rx
  • CBT promote recovery, decrease relapse,
    decrease Sx, more rapid discharge
  • Also for co-morbidity
  • CT Motivational interviewing, PE
  • FI building alliance
  • General PE and relapse prevention
  • Specific individualised FT- eg EE
  • OTHER- SST, CR, VR

33
  • Discharge planning
  • Sx reduction
  • Accommodation
  • Follow-up early engagement with CM
  • Available support
  • Risks ameliorated
  • Insight / adherence
  • Crisis plan
  • Rehab / Recovery early (lt1year) and
  • late phases (gt1 year)
  • Housing / Health
  • ADLs
  • Vocation
  • Education
  • Relapse prevention
  • Self-mx, social activities

34
Long-term interventions
35
(No Transcript)
36
Persistent Negative Sx
  • Affective blunting, Abulia (amotivation),
    Anhedonia, Alogia, ADLs impaired, Autism (social
    isolation)
  • Any phase of illness prodrome, acute, chronic
  • Significant impact on Fx
  • 20 Depression
  • Positive symptoms eg voices, persecutory
    delusions
  • Lack of social stimulation, institutionalisation
  • Medications EPSE, sedation
  • Substance abuse eg THC
  • Standardised scales for Ax - PANSS
  • Rx of 10 Negative Sx atypical APs- esp.
    amisulpiride 100-300mg
  • Aim for lower doses of atypicals (R 1-4, OLZ
    5-12.5)

37
Management of schizophrenia specific
interventions
  • From College CPG 2004

38
CPG psychopharmacology
39
CPG psychopharmacology
No haloperidol for acute agitation/emergencies
40
ECT for schizophrenia
41
Schizophrenia models of psychosocial care
Therapist Optimism has evidence for modulating
outcome
42
CPG psychosocial interventions
43
CPG psychosocial FI
44
CPG psychosocial FI
45
Assessing families in SCZ
  • Adjustment how have your family adjusted to
    having a family member with SCZ?
  • Boundaries / Roles what roles do you think the
    various family members take on in the family?
  • Communication- how does your family communicate?
  • Conflict How are disagreements dealt with?
  • Discipline who is in charge of laying down the
    rules of the home?
  • Difficulties how does your family go about
    resolving difficulties
  • Emotion is yours a family that expresses
    feelings very openly? What about negative
    feelings? When you are worried or frustrated with
    _, do you tend to be critical or overinvolved?
  • Expectation- how do you see _s future? What do
    you hope for him to achieve
  • Function How does your family function as a
    whole?

46
CPG psychosocial PE CBT
47
CPG psychosocial SST
Cognitive adaptation is like SST but tailored to
particular cognitive deficits
48
CPG psychosocial VR
49
Other psychosocial
50
Treatment resistance
51
Treating treatment resistance
  • DO NOT lose optimism
  • Exclude/treat mimickers
  • Use depot if non-adherent
  • USE CBT in everyone
  • Use clozapine
  • If clozapine fails go back to most effective past
    antipsychotic and add lithium
  • DO NOT use combined antipsychotics

52
Schizophrenia emergencies
53
Schizophrenia emergencies
54
Scz CPG odds ends
  • Private services 2001
  • 7.5 used inpatient
  • 13 had private insurance (vs. 30 in comm.)
  • 25 saw private psychiatrist

55
The CATIE trial Sep 05 NEJM Lieberman et al.
56
Schizophreniform disorder
  • Prodromal, active, and residual phases lt6 gt1 m
  • Impaired sociooccupational is not required for
    dWith Good Prognostic Features
  • 2
  • (1) onset of prominent psychotic symptoms within
    4 weeks of the first noticeable change in usual
    behavior or functioning(2) confusion or
    perplexity at the height of the psychotic
    episode(3) good premorbid social and
    occupational functioning(4) absence of blunted
    or flat affect

DSM 2/3 progress to schizophrenia/schizoaffective
disorder
57
Schizoaffective disorder
  • A. B C
  • Psychotic mood episode superimposed for a
    substantial portion of the total period of active
    residual illness with 2 weeks
    delusions/hallucinations without mood.
  • D. Gen med/substance exclusion
  • Bipolar Type or Depressive Type

58
Schizoaffective disorder
59
Delusional disorder
  • Non-bizarre delusions 1 m
  • Criterion A for Schizophrenia has never been met.
    Note Tactile and olfactory hallucinations may be
    present in Delusional Disorder if they are
    related to the delusional theme.
  • Functioning behaviour fine
  • Any mood is brief in relation to total period of
    delusions
  • Gen med/substance exclusion

60
Delusional disorder
  • Erotomanic Type delusions that another person,
    usually of higher status, is in love with the
    individual. Most clinical cases female, most
    forensic cases male.
  • Grandiose Type delusions of inflated worth,
    power, knowledge, identity, or special
    relationship to a deity or famous person
  • Jealous Type delusions that the individual's
    sexual partner is unfaithful
  • Persecutory Type (most common) delusions that
    the person (or someone to whom the person is
    close) is being malevolently treated in some way
  • Somatic Type delusions that the person has some
    physical defect or general medical condition
  • Mixed Type delusions characteristic of more than
    one of the above types but no one theme
    predominates
  • Unspecified Type

61
Brief psychotic disorder
  • 1
  • (1) delusions
  • (2) hallucinations
  • (3) disorganized speech (e.g., frequent
    derailment or incoherence)
  • (4) grossly disorganized or catatonic behavior
  • gt1d lt1m with eventual full return to premorbid
    level of functioning.
  • Other psychot/substance/gen med excl.
  • With Marked stressors
  • Without Marked stressors
  • With Postpartum onset (within 28 days)

62
Shared Psychotic Disorder (Folie a Deux)
  • A delusion develops in an individual in the
    context of a close relationship with another
    person(s), who has an already-established
    delusion.
  • The delusion is similar in content to that of the
    person who already has the established delusion.
  • C. Other psychot/gen med/substance excl

63
Psychotic disorder due to a GMC
  • Prominent hallucinations or delusions.
  • B. There is evidence from the history, physical
    examination, or laboratory findings that the
    disturbance is the direct physiological
    consequence of a GMC.
  • C. Not other MI.
  • D. Not delirium.

64
Psychotic disorder due to GMC
NEMO
65
Substance-induced psychotic disorder
  • A. Prominent hallucinations or delusions. Note
    Do not include hallucinations if the person has
    insight that they are substance induced.
  • B. Within 1 mo or intox/withdraw OR substance use
    aetiologically related to sx
  • C. Not other psychosis i.e. sx NOT
  • Precede drug use
  • In excess of whatd be expected with drug
  • Prolonged (gt 1month)
  • Part of previously known psychosis
  • D. Not delirium.

intoxication with the following classes of
substances alcohol amphetamine and related
substances cannabis cocaine hallucinogens
inhalants opioids (meperidine) phencyclidine
and related substances sedatives, hypnotics, and
anxiolytics withdrawal from the following
classes of substances alcohol sedatives,
hypnotics, and anxiolytics
66
Substance-induced psychotic disorder
  • Hallucinations may occur in any modality, but, in
    the absence of delirium, they are usually
    auditory. Alcohol-Induced Psychotic Disorder,
    With Hallucinations, usually occurs only after
    prolonged, heavy ingestion of alcohol in people
    who apparently have Alcohol Dependence. The
    auditory hallucinations are usually voices. The
    Psychotic Disorders induced by intoxication with
    amphetamine and cocaine share similar clinical
    features. Persecutory delusions may rapidly
    develop shortly after use of amphetamine or a
    similarly acting sympathomimetic. Distortion of
    body image and misperception of people's faces
    may occur. The hallucination of bugs or vermin
    crawling in or under the skin (formication) can
    lead to scratching and extensive skin
    excoriations. Cannabis-Induced Psychotic Disorder
    may develop shortly after high-dose cannabis use
    and usually involves persecutory delusions. The
    disorder is apparently rare. Marked anxiety,
    emotional lability, depersonalization, and
    subsequent amnesia for the episode can occur. The
    disorder usually remits within a day, but in some
    cases may persist for a few days.
    Substance-Induced Psychotic Disorders may at
    times not resolve promptly when the offending
    agent is removed. Agents such as amphetamines,
    phencyclidine, and cocaine have been reported to
    evoke temporary psychotic states that can
    sometimes persist for weeks or longer despite
    removal of the agent and treatment with
    neuroleptic medication. These may be initially
    difficult to distinguish from non-substance-induce
    d Psychotic Disorders. Some of the medications
    reported to evoke psychotic symptoms include
    anesthetics and analgesics, anticholinergic
    agents, anticonvulsants, antihistamines,
    antihypertensive and cardiovascular medications,
    antimicrobial medications, antiparkinsonian
    medications, chemotherapeutic agents (e.g.,
    cyclosporine and procarbazine), corticosteroids,
    gastrointestinal medications, muscle relaxants,
    nonsteroidal anti-inflammatory medications, other
    over-the-counter medications (e.g.,
    phenylephrine, pseudoephedrine), antidepressant
    medication, and disulfiram. Toxins reported to
    induce psychotic symptoms include
    anticholinesterase, organophosphate insecticides,
    nerve gases, carbon monoxide, carbon dioxide, and
    volatile substances such as fuel or paint

67
Psychotic Disorder Not Otherwise Specified
  • Postpartum psychosis that does not meet criteria
    for Mood Disorder With Psychotic Features, Brief
    Psychotic Disorder, Psychotic Disorder Due to a
    General Medical Condition, or Substance-Induced
    Psychotic Disorder
  • Psychotic symptoms that have lasted for less than
    1 month but that have not yet remitted, so that
    the criteria for Brief Psychotic Disorder are not
    met
  • Persistent auditory hallucinations in the absence
    of any other features
  • Persistent nonbizarre delusions with periods of
    overlapping mood episodes that have been present
    for a substantial portion of the delusional
    disturbance

68
Schneiders FRS (c. 1959)
  • 1. Auditory hallucinations
  • hearing thoughts spoken aloud (echo de la pensee
    gedankenlautwerden)
  • Two or more voices talking to each other
    referring to the patient as a third person
  • Commentary on ones actions
  • 2. Delusions
  • Passivity
  • thought withdrawal/insertion
  • feelings or actions experienced as made or
    influenced by external agents as if one was
    hypnotised or a robot
  • Thought broadcasting
  • 3. somatic passivity
  • sensations passively and reluctantly experienced
    as imposed by outside agencies
  • 4. delusional perception
  • a normal perception interpreted delusionally

69
Schneiders FRS (c. 1959)
  • No prognostic significance
  • 1 in 5 patients have never experienced a 1st rank
    symptom
  • 1 in 10 non-schizophrenic patients have
    experienced a 1st rank symptom
  • twin studies have shown that Schneiders 1st rank
    symptoms defined a form of schizophrenia with the
    least evidence of inheritance

70
Beyond the episode
71
Recovery model
  • Hope
  • Purpose/meaning/spirituality
  • Perspective on disorder (as part not whole of
    oneself)
  • Engagement community/work/new roles
  • Self-esteem
  • Self-care/basic functioning
  • Self-responsibility (e.g. relapse prevention,
    destructive habits)
  • Self-empowerment
  • Self-advocacy
Write a Comment
User Comments (0)
About PowerShow.com